Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of molecular signatures and pathways shared by Alzheimer’s disease and type 2 diabetes

20 Nov 2021

Abstract excerpt

Alzheimer's disease (AD) and type 2 diabetes (T2D) are common in the general elderly population, conferring heavy individual, social, and economic stresses on families and society. Accumulating evidence indicates T2D to be a risk factor for AD. However, the underlying mechanisms for this association are largely unknown. This study aimed to identify the shared molecular signatures between AD and T2D through...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Bioinformatics and Genomic Networks
Share to Computational Drug Discovery Methods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34813915
DOI: 10.1016/j.gene.2021.146070

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of molecular signatures and pathways shared by Alzheimer’s disease and type 2 diabetesPMID 34813915Read ↗

Transcriptomic and Network Analysis Highlight the Association of Diabetes at Different Stages of Alzheimer’s DiseaseSemantic proximity Read ↗

Identification of biomarkers and pathways to identify novel therapeutic targets in Alzheimer’s disease: Insights from a systems biomedicine perspectiveSemantic proximity Read ↗

Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspectiveSemantic proximity Read ↗

Identification and validation of oxidative stress and immune-related hub genes in Alzheimer’s disease through bioinformatics analysisSemantic proximity Read ↗

Shared Blood Transcriptomic Signatures between Alzheimer’s Disease and Diabetes MellitusSemantic proximity Read ↗

Identification and Experimental Validation of Marker Genes between Diabetes and Alzheimer’s DiseaseSemantic proximity Read ↗

Shared peripheral blood biomarkers for Alzheimer’s disease, major depressive disorder, and type 2 diabetes and cognitive risk factor analysisSemantic proximity Read ↗

A Network-Based Bioinformatics Approach to Identify Molecular Biomarkers for Type 2 Diabetes that Are Linked to the Progression of Neurological DiseasesSemantic proximity Read ↗

Exploring Shared Pathogenesis of Alzheimer’s Disease and Type 2 Diabetes Mellitus via Co-expression Networks AnalysisSemantic proximity Read ↗

Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics AnalysisSemantic proximity Read ↗

Identification of dysregulated genes and pathways of different brain regions in Alzheimer’s diseaseSemantic proximity Read ↗

Screening of Potential Biomarkers and Therapeutic Targets for T2DM-related Alzheimer's Disease Based on Bioinformatics AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.